Ambu A/S (OTCMKTS:AMBBY) Sees Unusually-High Trading Volume – Still a Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) saw unusually-strong trading volume on Friday . Approximately 500 shares traded hands during trading, an increase of 257% from the previous session’s volume of 140 shares.The stock last traded at $13.80 and had previously closed at $13.20.

Ambu A/S Trading Up 4.5%

The company has a current ratio of 2.72, a quick ratio of 1.63 and a debt-to-equity ratio of 0.08. The firm has a market cap of $3.24 billion, a PE ratio of 40.59 and a beta of 0.94. The business has a fifty day moving average price of $13.45 and a 200 day moving average price of $14.75.

Ambu A/S (OTCMKTS:AMBBY) last posted its earnings results on Wednesday, November 5th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 10.35% and a net margin of 10.00%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.